Jun 24 |
Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
|
Jun 21 |
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
Jun 20 |
Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
|
Jun 20 |
Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
May 15 |
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
|
May 15 |
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
|
May 15 |
AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates
|
May 15 |
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
|
May 14 |
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation
|
May 13 |
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
|